Peptide-Based Drug Discovery
A special issue of Scientia Pharmaceutica (ISSN 2218-0532).
Deadline for manuscript submissions: closed (31 March 2021) | Viewed by 524
Special Issue Editor
Interests: bioorganic & medicinal chemistry; computer-aided drug design and synthesis; green chemistry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Synthetic and natural peptides are recognized for their diverse therapeutic properties. Because of their highly selective and relatively safe nature, peptides are gaining interest in pharmaceutical research and development. Peptide chemistry is explored for the preparation of therapeutic peptides, signaling peptides, penetrating peptides, peptide–drug conjugates, cyclic peptides, and peptidomimetics. Currently, more than 140 peptide-based drug candidates are in clinical trials.
This Special Issue “Peptide-Based Drug Discovery” of Scientia Pharmaceutica welcomes the submission of research and review articles on peptide-based drug development, peptide delivery systems, peptide conjugate chemistry, and peptide synthesis to bring together recent advances in the field.
Dr. Siva Panda
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Scientia Pharmaceutica is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- peptide chemistry
- amino acids
- drug conjugates
- peptide synthesis
- drug development
- drug delivery
- coupling reagents
- peptidomimetics
- cyclic peptides
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
